Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Choose the right SP 500 fund for retirement in 2024 by evaluating fees, track record, and diversification.
24,199 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Nuclear energy is reclaiming attention as a reliable, low-emission power source. Here are three top picks that could ...
BingEx FLX is navigating a pivotal year. This article breaks down the Q4 2025 earnings, explains the key metrics, and...
Kymera’s CEO recently monetized a sizable stake after a strong run. This article unpacks the insider sale, what kymer...
As AI-driven growth cools, value stocks may take the lead. This guide shows how to spot undervalued names, avoid trap...
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
In today’s market briefing, Opendoor climbs as it nears a Russell 3000 inclusion, while broader indices tread water. ...
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...
Rivian faces a pivotal year as it scales both consumer and commercial EVs amid market volatility. This rivian stock p...
The US is accelerating domestic rare-earth initiatives, and investment banks keep raising targets on MP Materials. Th...
Jack in the Box reported softer results in its latest quarter, bringing attention to jack box's revenue sales trends....